PO
Patrick O'Brien
COO

Patrick O'Brien insider trades: Arrowhead Pharmaceuticals (ARWR) stock sales

COO, Arrowhead Pharmaceuticals Last trade Jan 5, 2026 21 Form 4 filings
$3.1M
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2019
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patrick reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 5, 2026ARWR↓ Sell$3.1M
Jan 7, 2025ARWR↓ Sell$736K
Jan 5, 2024ARWR↓ Sell$1.1M
Jan 5, 2023ARWR↓ Sell$561K
Jan 3, 2023ARWR↓ Sell$671K
Jan 5, 2022ARWR↓ Sell$2.0M
Feb 8, 2021ARWR↓ Sell$8.0M
Jan 6, 2021ARWR↓ Sell$1.8M
Jan 6, 2020ARWR↓ Sell$879K
May 28, 2019ARWR↓ Sell$746K
Jan 18, 2019ARWR↓ Sell$1.0M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ARWR insiders

Open-market trades in the last 12 months

About Patrick O'Brien's insider trades

Patrick O'Brien is COO at Arrowhead Pharmaceuticals (ARWR). Since Jan 18, 2019, Patrick has reported no open-market purchases and 11 sales worth $20.7M on SEC Form 4. In the last 12 months: 1 sale ($3.1M).

Their filings also include grants and awards (12 filings), gifts (3 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARWR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.